Home › Research › Prevention and risk
Rationale and Design of the Hamburg City Health Study
Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, Augustin M, der Kellen RB et al.. European journal of epidemiology, 2019-11-08
Topic: Risk, prevention and care in population studies
Plain-language summary
The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several important risk and prognostic factors in major chronic diseases. A random sample of 45,000 participants between 45 and 74 years of age from the general population of Hamburg, Germany, are taking part in an extensive baseline assessment at one dedicated study center. Participants undergo 13 validated and 5 novel examinations primarily targeting major organ system function and structures including extensive imaging examinations. The protocol includes validate self-reports via questionnaires regarding lifestyle and environmental conditions, dietary habits, physical condition and activity, sexual dysfunction, professional life, psychosocial context and burden, quality of life, digital media use, occupational, medical and family history as well as healthcare utilization. The assessment is completed by genomic and proteomic characterization. Beyond the identification of classical risk factors for major chronic diseases and survivorship, the core intention is to gather valid prevalence and incidence, and to develop complex models predicting health outcomes based on a multitude of examination data, imaging, biomarker, psychosocial and behavioral assessments. Participants at risk for coronary artery disease, atrial fibrillation, heart failure, stroke and dementia are invited for a visit to conduct an additional MRI examination of either heart or brain. Endpoint assessment of the overall sample will be completed through repeated follow-up examinations and surveys as well as related individual routine data from involved health and pension insurances. The study is targeting the complex relationship between biologic and psychosocial risk and resilience factors, chronic disease, health care use, survivorship and health as well as favorable and bad prognosis within a unique, large-scale long-term assessment with the perspective of further examinations after 6 years in a representative European metropolitan population.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 45,000 participants. This paper describes the design of the Hamburg City Health Study, a large prospective population-based cohort of 45,000 participants aged 45 to 74. It is a research platform for studying risk and prognostic factors in chronic diseases and does not report any treatment, cure, or prevention of Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Jagodzinski, A., Johansen, C., Koch-Gromus, U., Aarabi, G., Adam, G., Anders, S., et al. (2020). Rationale and Design of the Hamburg City Health Study. European journal of epidemiology. https://doi.org/10.1007/s10654-019-00577-4
Vancouver
Jagodzinski A, Johansen C, Koch-Gromus U, Aarabi G, Adam G, Anders S, et al. Rationale and Design of the Hamburg City Health Study. European journal of epidemiology. 2020. doi:10.1007/s10654-019-00577-4. PMID: 31705407.
BibTeX
@article{jagodzinski2020-31705407,
author = {Jagodzinski, A. and Johansen, C. and Koch-Gromus, U. and Aarabi, G. and Adam, G. and Anders, S. and Augustin, M. and der Kellen, R. B. and others},
title = {{Rationale and Design of the Hamburg City Health Study}},
journal = {European journal of epidemiology},
year = {2020},
doi = {10.1007/s10654-019-00577-4},
pmid = {31705407},
url = {https://doi.org/10.1007/s10654-019-00577-4}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Endpoint assessment of the overall sample will be completed through repeated follow-up examinations and surveys as well as related individual routine data from involved health and pension insurances.
Why it matters
This paper describes the design of the Hamburg City Health Study, a large prospective population-based cohort of 45,000 participants aged 45 to 74. It is a research platform for studying risk and prognostic factors in chronic diseases and does not report any treatment, cure, or prevention of Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designcohort study
- Participants45,000
- Evidence strengthModerate
How this study scored 65/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (European journal of epidemiology) |
| Journal's citation record | 2 / 4 | European Journal of Epidemiology: journal h-index 175 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 4 / 4 | 45,000 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 154 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 19.2 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 4 / 6 | Cited 8.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 3 / 4 | Cited 72 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Stefan Blankenberg: h-index 122 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Universität Hamburg: institution h-index 875 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 31705407) |
| Free to read | 2 / 2 | Free to read |
| Total | 65 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1007/s10654-019-00577-4
- PubMed: 31705407
- Original source →
- Free full text: European Journal of Epidemiology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
267 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.